Credit Suisse Group restated their buy rating on shares of GoHealth (NASDAQ:GOCO) in a report released on Thursday morning, AnalystRatings.com reports. Credit Suisse Group currently has a $25.00 target price on the stock.
Several other research analysts also recently commented on the company. Barclays assumed coverage on GoHealth in a research report on Monday, August 10th. They issued an overweight rating and a $22.00 price target on the stock. William Blair assumed coverage on GoHealth in a research report on Tuesday, August 11th. They issued an outperform rating on the stock. Evercore ISI assumed coverage on GoHealth in a research report on Sunday, August 9th. They issued an outperform rating and a $27.00 price target on the stock. Truist Financial started coverage on GoHealth in a research report on Monday, August 10th. They issued a buy rating on the stock. Finally, Cantor Fitzgerald started coverage on GoHealth in a report on Monday, August 10th. They set an overweight rating and a $26.00 price objective on the stock. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The company currently has a consensus rating of Buy and an average target price of $22.78.
Shares of GOCO traded down $0.57 during midday trading on Thursday, reaching $16.46. 14,797 shares of the stock were exchanged, compared to its average volume of 1,613,016. GoHealth has a 12-month low of $15.14 and a 12-month high of $26.25.
GoHealth Company Profile
GoHealth, Inc operates a health insurance marketplace to enhance access to healthcare in the United States. The company, through its platform, offer various health insurance policies, including Medicare advantage, Medicare supplement, Medicare prescription drug plans, and Medicare special needs plans; and individual and family, dental, vision, and other related plans.
Featured Story: What is the G-20?
Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.